TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ABSI

Absci Corp

Healthcare · Biotechnology

10.30$ -10.9% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Absci Corp (ABSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 269 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABSI
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 89 223 257 449 426 395 366 339 321 296 254 236 217 275 256 235 214 232 210 245 216 196 269
13 – – 73 185 112 301 273 256 228 201 187 165 148 135 121 182 165 150 134 156 137 175 150 132 208
-13 – – 70 181 99 279 253 226 206 107 60 11 61 70 72 59 43 38 41 47 38 9.5 20 8.6 108
13 – – 70 181 99 279 253 226 206 181 164 144 125 113 98 162 145 127 112 134 117 152 144 126 201
– – – 1.6 1.0 0.5 0.7 1.4 0.4 0.3 0.2 1.6 1.3 3.2 0.8 2.2 0.0 0.0 1.5 0.0 1.4 0.7 1.0 – – –
– – – 0.0 0.0 11 11 11 23 15 15 15 15 15 16 – 0.0 – – – – – – – – –
– – – – 29 45 51 59 61 61 61 58 55 – – – – – – – – – – – – –
– – – – 1.1 23 23 21 21 21 21 21 21 0.0 0.0 0.0 – – – – – – – – – –
– – – – 2.4 57 56 55 54 53 52 52 51 50 49 48 47 47 46 45 44 43 42 42 41 40
– – – 22 160 220 61 60 55 50 46 47 42 39 40 41 35 34 34 34 34 37 35 27 24 23
– – – 10 17 30 30 34 42 32 30 30 27 25 28 30 25 25 27 29 27 31 30 23 20 20
– – – 3.8 4.1 5.0 6.6 6.7 6.7 11 11 6.9 6.8 6.4 6.0 5.6 5.2 4.9 5.0 4.4 4.2 3.7 3.1 2.7 2.3 2.0
– – – 2.1 8.4 9.0 6.4 8.4 6.7 5.5 1.9 2.4 1.9 1.9 1.9 1.5 1.7 1.7 1.7 3.5 4.9 8.2 4.6 2.8 8.8 16
– – – 4.1 129 153 1.7 1.1 0.5 7.1 6.5 8.0 7.2 6.4 5.5 4.7 3.7 3.1 2.2 1.3 0.7 0.2 0.1 – – –
12 – – 67 63 37 388 366 340 316 293 274 254 215 196 176 240 221 201 179 199 173 210 189 172 246
– – – -90 -101 -142 -166 -191 -221 -249 -276 -296 -319 -361 -383 -406 -428 -453 -481 -510 -536 -567 -595 -625 -654 -688
90 90 90 90 90 90 73 90 90 91 91 91 91 92 92 93 99 113 114 115 124 128 144 151 153 157

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?